Glutamate transporters: Animal models to neurologic disease

Research output: Contribution to journalArticle

Abstract

Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease.

Original languageEnglish (US)
Pages (from-to)461-473
Number of pages13
JournalNeurobiology of Disease
Volume15
Issue number3
DOIs
StatePublished - Apr 2004

Fingerprint

Amino Acid Transport System X-AG
Nervous System Diseases
Animal Models
Central Nervous System
Central Nervous System Neoplasms
Excitatory Amino Acids
Neurodegenerative Diseases
Neurotransmitter Agents
Glutamic Acid
Epilepsy
Proteins
Cell Death
Stroke

Keywords

  • Central nervous system
  • Glutamate
  • Neurologic diseases

ASJC Scopus subject areas

  • Neurology

Cite this

Glutamate transporters : Animal models to neurologic disease. / Maragakis, Nicholas J; Rothstein, Jeffrey D.

In: Neurobiology of Disease, Vol. 15, No. 3, 04.2004, p. 461-473.

Research output: Contribution to journalArticle

@article{572a07ed91e34a37873b33d4a6e18b27,
title = "Glutamate transporters: Animal models to neurologic disease",
abstract = "Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease.",
keywords = "Central nervous system, Glutamate, Neurologic diseases",
author = "Maragakis, {Nicholas J} and Rothstein, {Jeffrey D}",
year = "2004",
month = "4",
doi = "10.1016/j.nbd.2003.12.007",
language = "English (US)",
volume = "15",
pages = "461--473",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Glutamate transporters

T2 - Animal models to neurologic disease

AU - Maragakis, Nicholas J

AU - Rothstein, Jeffrey D

PY - 2004/4

Y1 - 2004/4

N2 - Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease.

AB - Glutamate is the primary excitatory amino acid neurotransmitter in the central nervous system and its activity is carefully modulated in the synaptic cleft by glutamate transporters. A number of glutamate transporters have been identified in the central nervous system and each has a unique physiologic property and distribution. Glutamate transporter dysfunction may either be an initiating event or part of a cascade leading to cellular dysfunction and ultimately cell death. Animal models of glutamate transporter dysfunction have revealed a significant role for these proteins in pathologic conditions such as neurodegenerative diseases, epilepsy, stroke, and central nervous system tumors. Recent work has focused on glutamate transporter biology in human diseases with an emphasis on how manipulation of these transporter proteins may lead to therapeutic interventions in neurologic disease.

KW - Central nervous system

KW - Glutamate

KW - Neurologic diseases

UR - http://www.scopus.com/inward/record.url?scp=1842524064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842524064&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2003.12.007

DO - 10.1016/j.nbd.2003.12.007

M3 - Article

C2 - 15056453

AN - SCOPUS:1842524064

VL - 15

SP - 461

EP - 473

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 3

ER -